The nation’s drug problem is commercial recreational pharmacology

The nation’s drug problem is commercial recreational pharmacology
Drs. Robert L. DuPont and Sharon Levy have written a brilliant paper that calls on us to view the drug problem as commercial recreational pharmacology, which they define as “the personally controlled use of psychoactive drugs that super-stimulate brain reward for pleasure.” Greater acceptance of drug use and its commercialization is exacting a toll on the nation’s public health. One example is a decline in US life expectancy, which fell three years in a row from 2016 and was driven by overdose deaths.

The researchers explain that until the 1960s, most drug use was confined to just a few drugs. But as the baby boom generation became adolescents, drug use began to be more tolerated, and an array of drugs gradually became available. This shift led to today’s opioid epidemic, marijuana legalization, and the youth vaping epidemic.

New drugs and new ways to consume them add up to huge profits for their makers. Americans spend $254 billion on alcohol, $125 billion on tobacco, and $150 billion on illicit drugs.  And thus, the acceptance of recreational pharmacology in the 60s has morphed into commercialized recreational pharmacology today.

The researchers advise “a seismic shift in our shared cultural understanding of recreational drug use from one promoted by both legal and illegal commercial interests to one based on public health science that recognizes recreational drug use as a major health risk behavior.”

We highly recommend this paper to our readers for the authors’ insights into the overall drug problem and their intelligent advice on how we can resolve it. Only the abstract is available for free, but you can “rent” the article for 48-hour online access for $7. It’s well worth the money.

Read Alcoholism and Drug Abuse Weekly abstract here.

Like this article?

Share on facebook
Share on Facebook
Share on twitter
Share on Twitter
Share on linkedin
Share on Linkdin
Share on pinterest
Share on Pinterest

Leave a comment

Related Posts

Case Reports on the Failure of Smoking Marijuana to Prevent Relapse to Use of Opiates in Adolescents/Young Adults With Opiate Use Disorder

Case Reports on the Failure of Smoking Marijuana to Prevent Relapse to Use of Opiates in Adolescents/Young Adults With Opiate Use Disorder Twenty-six adolescent/young adult patients with opioid use disorder smoked marijuana in an attempt to avoid relapse to opiate use. In each case, smoking marijuana increased cravings and urges for opiates and promoted opiate

San Diego Rx Abuse Task Force Hosts Marijuana Drug Interactions Media Event

San Diego Rx Abuse Task Force recently hosted the marijuana drug interactions media event, which was live-streamed on Facebook on September 9. This is an innovative project – probably the first of its kind – alerting consumers on drug interactions with cannabis products and evaluating the importance of this information to the public. Watch online

What Policy is Effective to Decrease Drug Use in America?

Hear a discussion with Dr. Bertha Madras on High Truths on Drugs and Addiction, Episode #12. Dr. Madras is an IASIC scientific advisor, Harvard Professor and former White House Office of National Drug Control Policy Deputy Director of Demand Reduction. In episode #12, Dr. Madras explains the importance and possible prevention of drug use. The

Scroll to Top